APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Osimertinib Drugs Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchOsimertinib Drugs Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Drugs Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Osimertinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Osimertinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Osimertinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Osimertinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osimertinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Osimertinib Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Osimertinib Drugs market include AstraZeneca. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Osimertinib Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Osimertinib Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Osimertinib Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Osimertinib Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Osimertinib Drugs Segment by Company

AstraZeneca

Osimertinib Drugs Segment by Type

40mg

80mg

Osimertinib Drugs Segment by Application

Hospital

Drugs Store

Osimertinib Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Osimertinib Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Osimertinib Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Osimertinib Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Osimertinib Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Osimertinib Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Osimertinib Drugs industry.

Chapter 3: Detailed analysis of Osimertinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Osimertinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Osimertinib Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Osimertinib Drugs Industry Trends Table 2. Osimertinib Drugs Industry Drivers Table 3. Osimertinib Drugs Industry Opportunities and Challenges Table 4. Osimertinib Drugs Industry Restraints Table 5. Global Osimertinib Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Osimertinib Drugs Revenue Share by Company (2021-2026) Table 7. Global Osimertinib Drugs Sales Volume by Company (Units) & (2021-2026) Table 8. Global Osimertinib Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Osimertinib Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Osimertinib Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Osimertinib Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Osimertinib Drugs Company, Product Type & Application Table 13. Global Osimertinib Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Osimertinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40mg Table 18. Significant Companies of 80mg Table 19. Global Osimertinib Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Osimertinib Drugs Sales Volume by Type (2021-2026) & (Units) Table 21. Global Osimertinib Drugs Sales Volume by Type (2027-2032) & (Units) Table 22. Global Osimertinib Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Osimertinib Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Osimertinib Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Osimertinib Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Osimertinib Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Osimertinib Drugs Sales Value Share by Type (2021-2026) Table 28. Global Osimertinib Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drugs Store Table 31. Global Osimertinib Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Osimertinib Drugs Sales Volume by Application (2021-2026) & (Units) Table 33. Global Osimertinib Drugs Sales Volume by Application (2027-2032) & (Units) Table 34. Global Osimertinib Drugs Sales Volume Share by Application (2021-2026) Table 35. Global Osimertinib Drugs Sales Volume Share by Application (2027-2032) Table 36. Global Osimertinib Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Osimertinib Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Osimertinib Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Osimertinib Drugs Sales Value Share by Application (2021-2026) Table 40. Global Osimertinib Drugs Sales Value Share by Application (2027-2032) Table 41. Global Osimertinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Osimertinib Drugs Sales by Region (2021-2026) & (Units) Table 43. Global Osimertinib Drugs Sales Market Share by Region (2021-2026) Table 44. Global Osimertinib Drugs Sales by Region (2027-2032) & (Units) Table 45. Global Osimertinib Drugs Sales Market Share by Region (2027-2032) Table 46. Global Osimertinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Osimertinib Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Osimertinib Drugs Sales Value Share by Region (2021-2026) Table 49. Global Osimertinib Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Osimertinib Drugs Sales Value Share by Region (2027-2032) Table 51. Global Osimertinib Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Osimertinib Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Osimertinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Global Osimertinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Osimertinib Drugs Sales by Country (2021-2026) & (Units) Table 56. Global Osimertinib Drugs Sales Market Share by Country (2021-2026) Table 57. Global Osimertinib Drugs Sales by Country (2027-2032) & (Units) Table 58. Global Osimertinib Drugs Sales Market Share by Country (2027-2032) Table 59. Global Osimertinib Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Osimertinib Drugs Sales Value Market Share by Country (2021-2026) Table 61. Global Osimertinib Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Osimertinib Drugs Sales Value Market Share by Country (2027-2032) Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Osimertinib Drugs Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. AstraZeneca Osimertinib Drugs Product Portfolio Table 67. AstraZeneca Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Osimertinib Drugs Distributors List Table 71. Osimertinib Drugs Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Osimertinib Drugs Product Image Figure 2. Global Osimertinib Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Osimertinib Drugs Sales (2021-2032) & (Units) Figure 5. Global Osimertinib Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Osimertinib Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40mg Image Figure 10. 80mg Image Figure 11. Global Osimertinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Osimertinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Osimertinib Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Osimertinib Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Osimertinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Osimertinib Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drugs Store Image Figure 19. Global Osimertinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Osimertinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Osimertinib Drugs Sales Volume Share by Application (2021-2032) Figure 22. Global Osimertinib Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Osimertinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Osimertinib Drugs Sales Value Share by Application (2021-2032) Figure 25. Global Osimertinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 26. Global Osimertinib Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Osimertinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Osimertinib Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Osimertinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. North America Osimertinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Osimertinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Osimertinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Osimertinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Osimertinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Osimertinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. South America Osimertinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Osimertinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Osimertinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Osimertinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Osimertinib Drugs Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Osimertinib Drugs Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Hospital
  • Drugs Store
Companies covered
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Osimertinib Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Osimertinib Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Osimertinib Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Osimertinib Drugs Market Dynamics
  1. 2.1 Osimertinib Drugs Industry Trends
  2. 2.2 Osimertinib Drugs Industry Drivers
  3. 2.3 Osimertinib Drugs Industry Opportunities and Challenges
  4. 2.4 Osimertinib Drugs Industry Restraints
3 Osimertinib Drugs Market by Company
  1. 3.1 Global Osimertinib Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Osimertinib Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Osimertinib Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Osimertinib Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Osimertinib Drugs Company Ranking (2024-2026)
  6. 3.6 Global Osimertinib Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Osimertinib Drugs Company Product Type and Application
  8. 3.8 Global Osimertinib Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Osimertinib Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Osimertinib Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Osimertinib Drugs Market by Type
  1. 4.1 Osimertinib Drugs Type Introduction
  2. 4.1.1 40mg
  3. 4.1.2 80mg
  4. 4.2 Global Osimertinib Drugs Sales Volume by Type
  5. 4.2.1 Global Osimertinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Osimertinib Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Osimertinib Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Osimertinib Drugs Sales Value by Type
  9. 4.3.1 Global Osimertinib Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Osimertinib Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Osimertinib Drugs Sales Value Share by Type (2021-2032)
5 Osimertinib Drugs Market by Application
  1. 5.1 Osimertinib Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.2 Global Osimertinib Drugs Sales Volume by Application
  5. 5.2.1 Global Osimertinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Osimertinib Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Osimertinib Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Osimertinib Drugs Sales Value by Application
  9. 5.3.1 Global Osimertinib Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Osimertinib Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Osimertinib Drugs Sales Value Share by Application (2021-2032)
6 Osimertinib Drugs Regional Sales and Value Analysis
  1. 6.1 Global Osimertinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Osimertinib Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Osimertinib Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Osimertinib Drugs Sales by Region (2027-2032)
  5. 6.3 Global Osimertinib Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Osimertinib Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Osimertinib Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Osimertinib Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Osimertinib Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Osimertinib Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Osimertinib Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Osimertinib Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Osimertinib Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Osimertinib Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Osimertinib Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Osimertinib Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Osimertinib Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Osimertinib Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Osimertinib Drugs Sales Value Share by Country, 2025 VS 2032
7 Osimertinib Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Osimertinib Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Osimertinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Osimertinib Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Osimertinib Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Osimertinib Drugs Sales by Country (2027-2032)
  6. 7.4 Global Osimertinib Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Osimertinib Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Osimertinib Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Osimertinib Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Osimertinib Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Osimertinib Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Osimertinib Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Osimertinib Drugs Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Osimertinib Drugs Value Chain Analysis
  2. 9.1.1 Osimertinib Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Osimertinib Drugs Sales Mode & Process
  6. 9.2 Osimertinib Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Osimertinib Drugs Distributors
  9. 9.2.3 Osimertinib Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst